Tailor-made sugar coated proteins manufactured in novel E. coli system

November 28, 2002

The prospect of using bacteria to manufacture complex human proteins for use in therapeutic drugs is a step closer thanks to new research published today in Science.

Researchers from Switzerland and the UK report they have engineered the bacterium Escherichia coli to carry a vital piece of cell machinery that adds sugar molecules to newly synthesized proteins by a process known as glycosylation.

The finding opens up the possibility of producing complex human proteins such as Factor VIII and the hormone erythropoietin, which stimulates the production of red blood cells by stem cells in bone marrow. Both these proteins, which require the addition of sugar molecules to function properly, are currently produced by culturing mammalian cells, which can be a costly and technically difficult process.

The addition of sugars to proteins by glycosylation is crucial in defining their job in the body by helping them fold into a particular three-dimensional shape that determines how they interact with other proteins.

Simple bacterial cells normally do not possess the same type of cellular machinery used for glycosylation in higher organisms like humans. Until now this has restricted the types of human proteins that can be produced in bacteria.

The team of scientists from the Swiss Federal Institute of Technology, Zurich, the London School of Hygiene and Tropical Medicine and Imperial College London have shown that the bacterium Campylobacter jejuni uniquely contains glycosylation machinery similar to the type found in higher organisms. They have developed a technique of transferring this machinery into the E. coli bacterium, which is widely used in the industrial production of proteins.

Professor Anne Dell of Imperial College London said:

"We are only now beginning to understand the vital biological role sugars play in monitoring and guiding the day-to-day lives of the cells in our bodies. This work opens a path for the production of tailor-made glycoproteins in high abundance for applications in research and industry."

Using new high sensitivity mass spectrometers housed in the Department of Biological Sciences together with facilities in the M-Scan Mass Spectrometry Research and Training Centre, Ascot, the Imperial research team headed by Professor Dell and Professor Howard Morris were able to identify the precise nature of glycosylation in C. jejuni, including the exact position where sugars are attached to proteins.

Colleagues in Zurich were then able to insert the C. jejuni glycosylation machinery into E coli and test whether it worked using mutational analysis.

"We have only begun to scratch the surface in understanding important role sugars play in our body," said Professor Dell. "Many common diseases including certain types of rheumatoid arthritis and muscular dystrophy have already been linked to disruption of the delicate balance of sugars displayed on the surface of proteins. Deciphering these complex interactions will be significantly aided by the new tool our research has developed."

Professor Brendan Wren of the London School of Hygiene and Tropical Medicine added:

"C. jejuni is recognised to be the major bacterial cause of gastro-intestinal diseases worldwide and can lead to the development of serious neurological disease. Despite the importance of the organism it is very poorly understood. Apart from its potential in glycoengineering, the newly characterised glycosylation system will also be useful in the development of vaccines to reduce the burden of Campylobacter-related disease".
-end-
The Imperial College London research infrastructure was funded by a JIF grant, which involves partnership between the Wellcome Trust, the Office of Science and Technology and the Higher Education Funding Council for England. Additional support was provided by the Biotechnology and Biological Sciences Research Council (BBSRC) and the Wellcome Trust. Professor Anne Dell currently holds a BBSRC Professorial Fellowship.

For further information, please contact:

Judith H Moore
Imperial College London Press Office
Tel: +44 (0)20 7594 6702
Mobile: +44 (0)7803 886 248
E-mail: j.h.moore@imperial.ac.uk

Lindsay Wright
London School of Hygiene and Tropical Medicine Press Office
Tel: +44 (0)20 7927 2073
Email: Lindsay.Wright@lshtm.ac.uk

Notes to editors

Journal: Science

Title: "N-Linked Glycosylation in Campylobacter jejuni and Its Functional Transfer into Escherichia coli" Science (29 November 2002)

Authors: Michael Wacker (1), Dennis Linton (2), Paul G Hitchen (3), Mihai Nita-Lazar (1), Stuart M. Haslam (3), Simon J. North (3), Maria Panico (3), Howard R. Morris (3,4), Anne Dell (3), Brendan W. Wren (2), Markus Aebi (1)

1. Institute of Microbiology, Department of biology Swiss Federal Institute of Technology, Zurich, CH 8092 Zurich, Switzerland.

2. Department of Infectious and Tropical Disease, London School of Hygiene and Tropical Disease, London, WC1E 7HT, UK

3.Department of Biological Sciences, Imperial College London, SW7 2AZ, UK

4. M-SCAN Mass Spectrometry Research and Training Centre, Silwood Park, Ascot, SL5 7PZ, UK

About the Swiss Federal Institute of Technology Zurich

The name is known throughout the world: The Swiss Federal Institute of Technology Zurich is a science and technology university with an outstanding research record. Excellent research conditions, state-of-the-art infrastructure and an attractive urban environment add up to the ideal setting for creative personalities. 20'000 people from Switzerland and abroad are currently studying, working or conducting research at ETH Zurich. ETH earned its excellent national and international reputation through major achievements in research as well as through first-rate teaching and services.

About London School of Hygiene and Tropical Medicine

The London School of Hygiene and Tropical Medicine is a renowned research-led postgraduate medical school with a unique mission to contribute to the improvement of health worldwide through the pursuit of excellence in research, post graduate teaching, advanced training and consultancy in international public health and tropical medicine. As it enters its second century the School's commitment to excellence and its leadership role in these subject areas has never been more evident.

About Imperial College London

Consistently rated in the top three UK university institutions, Imperial College London is a world leading science-based university whose reputation for excellence in teaching and research attracts students (10,000) and staff (5000) of the highest international quality.

Innovative research at the College explores the interface between science, medicine, engineering and management and delivers practical solutions, which enhance the quality of life and the environment - underpinned by a dynamic enterprise culture. Website: www.imperial.ac.uk

Imperial College London

Related Proteins Articles from Brightsurf:

New understanding of how proteins operate
A ground-breaking discovery by Centenary Institute scientists has provided new understanding as to the nature of proteins and how they exist and operate in the human body.

Finding a handle to bag the right proteins
A method that lights up tags attached to selected proteins can help to purify the proteins from a mixed protein pool.

Designing vaccines from artificial proteins
EPFL scientists have developed a new computational approach to create artificial proteins, which showed promising results in vivo as functional vaccines.

New method to monitor Alzheimer's proteins
IBS-CINAP research team has reported a new method to identify the aggregation state of amyloid beta (Aβ) proteins in solution.

Composing new proteins with artificial intelligence
Scientists have long studied how to improve proteins or design new ones.

Hero proteins are here to save other proteins
Researchers at the University of Tokyo have discovered a new group of proteins, remarkable for their unusual shape and abilities to protect against protein clumps associated with neurodegenerative diseases in lab experiments.

Designer proteins
David Baker, Professor of Biochemistry at the University of Washington to speak at the AAAS 2020 session, 'Synthetic Biology: Digital Design of Living Systems.' Prof.

Gone fishin' -- for proteins
Casting lines into human cells to snag proteins, a team of Montreal researchers has solved a 20-year-old mystery of cell biology.

Coupled proteins
Researchers from Heidelberg University and Sendai University in Japan used new biotechnological methods to study how human cells react to and further process external signals.

Understanding the power of honey through its proteins
Honey is a culinary staple that can be found in kitchens around the world.

Read More: Proteins News and Proteins Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.